454 filings
Page 4 of 23
6-K
jlql8yqyb
6 Jan 23
Report of Foreign Private Issuer
7:00am
6-K
3mvve999v15kr3hf3t2y
3 Jan 23
Purple Biotech and Mor Research Applications Announce Research Collaboration to Identify Promising Investigational Oncology Treatments
7:03am
UPLOAD
9byrms3agf 51u25dn3b
12 Dec 22
Letter from SEC
12:00am
F-3
t5l4wgapo54pzj
7 Dec 22
Shelf registration (foreign)
9:17pm
6-K
u5edoyay
15 Nov 22
Report of Foreign Private Issuer
7:03am
6-K
seygqp evld23r1c
9 Nov 22
Report of Foreign Private Issuer
4:11pm
6-K
qkvfxyoamaviawo
8 Nov 22
Purple Biotech Reports Third Quarter 2022 Financial Results
7:56am
6-K
bp8hxpwtppy94jn
2 Nov 22
Purple Biotech Appoints Lior Fhima as Chief Financial Officer
7:39am
6-K
ifjgi
25 Aug 22
Report of Foreign Private Issuer
4:10pm
6-K
jj1ykp
4 Aug 22
Purple Biotech Reports Second Quarter 2022 Financial Results
7:31am
6-K
fx2b pbwb05gdk4h2
18 Jul 22
Notice of Annual General Meeting of Shareholders
4:25pm
6-K
8hbknd1uiqz s2txw63d
14 Jul 22
Purple Biotech Announces Executive Leadership Changes
7:31am
6-K
48h 9892iw4x82xk
6 Jun 22
Report of Foreign Private Issuer
7:33am
6-K
rio cwuijyrg
27 May 22
Report of Foreign Private Issuer
7:15am
6-K
m22 s1r5xad2
18 May 22
Purple Biotech Announces the Initiation of Phase 2 Study for CM24 in 2L PDAC Patients
8:08am
6-K
ak1ebf2isme
12 May 22
Purple Biotech Reports First Quarter 2022 Financial Results
8:14am
6-K
mww5nd 25fmr
2 May 22
Report of Foreign Private Issuer
4:10pm
6-K/A
dyt5o q2bp8
11 Apr 22
Purple Biotech Presents Positive Interim Phase 1b Study Results for CM24 at the American Association of Cancer Research 2022 Annual Meeting
4:10pm
6-K
nfyualikoqqm6evs57ap
11 Apr 22
Purple Biotech Presents Positive Interim Phase 1b Study Results for CM24 at the American Association of Cancer Research 2022 Annual Meeting
7:38am
S-8
h7psw
4 Apr 22
Registration of securities for employees
4:11pm